Literature DB >> 14579140

Lupus vasculopathy combined with acute renal failure in lupus nephritis.

Chien-Te Wu1, Lin-Shien Fu, Mei-Chin Wen, Shein-Chung Hung, Ching-Shiang Chi.   

Abstract

Several risk factors have been associated with the prognosis of lupus nephritis. However, few studies have focused on renal vascular lesions (such as thrombi due to immune complexes) as a prognostic factor in this disease. Here we present a case of systemic lupus erythematosus (SLE) in a 12-year-old girl who exhibited acute renal failure and severe hypertension on admission. Renal pathology findings included diffuse proliferative glomerulonephritis (class IVb) and lupus vasculopathy (LV) with immune complex deposition within glomerular capillaries and the preglomerular arteriolar lumen. Her clinical condition deteriorated rapidly, even after cyclophosphamide and methylprednisolone pulse therapy. It improved after 5 days of plasmapheresis and remained stable for up to 6 months under regular treatment. We suggest that renal biopsy performed early in SLE patients with renal involvement should be studied carefully for the presence of vascular lesions. Additionally, plasmapheresis can be considered in patients with LV refractory to other modalities of therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579140     DOI: 10.1007/s00467-003-1266-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

Review 1.  Guidelines for looking at the antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  P Stratta; C Canavese; S Ferrero; A Grill; G Piccoli
Journal:  Nephron       Date:  1997       Impact factor: 2.847

2.  Massive uncomplicated vascular immune complex deposits in the kidney of a patient with systemic lupus erythematosus.

Authors:  K Takazoe; T Shimada; H Nakano; T Kawamura; Y Utsunomiya; T Kanai; T Kitajima; Y Yamaguchi; K Joh; T Mitarai; O Sakai
Journal:  Clin Nephrol       Date:  1997-09       Impact factor: 0.975

3.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; S P Lan; R D Rohde; J M Lachin
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

Review 4.  Apheresis for lupus erythematosus.

Authors:  D J Wallace
Journal:  Lupus       Date:  1999       Impact factor: 2.911

Review 5.  Lupus nephritis: a clinical review for practicing nephrologists.

Authors:  G Contreras; D Roth; V Pardo; L G Striker; D R Schultz
Journal:  Clin Nephrol       Date:  2002-02       Impact factor: 0.975

6.  Renal vascular lesions in lupus nephritis.

Authors:  E Descombes; D Droz; L Drouet; J P Grünfeld; P Lesavre
Journal:  Medicine (Baltimore)       Date:  1997-09       Impact factor: 1.889

Review 7.  Immunosuppressive therapy of lupus nephritis.

Authors:  M A Dooley; R J Falk
Journal:  Lupus       Date:  1998       Impact factor: 2.911

8.  Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

Authors:  G Banfi; T Bertani; V Boeri; T Faraggiana; G Mazzucco; G Monga; G Sacchi
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

9.  Systemic lupus erythematosus presented as non-inflammatory necrotizing vasculopathy-induced ischemic glomerulopathy and small vessels-related ischemic cardiomyopathy.

Authors:  J M Sung; S C Hsu; F F Chen; J J Huang
Journal:  Lupus       Date:  2002       Impact factor: 2.911

  9 in total
  2 in total

1.  Characteristics and influence factors of pathologic transformation in the subclasses of class IV lupus nephritis.

Authors:  Jian-jun Gao; Guang-yan Cai; Shu-wen Liu; Li Tang; Xue-guang Zhang; Yang Yang; Pu Chen; Shu-xin Liu; Jia-yao Ji; Suo-zhu Shi; Zhong Yin; Xiang-mei Chen
Journal:  Rheumatol Int       Date:  2011-03-26       Impact factor: 2.631

2.  A girl with difficult lupus nephritis: lupus vasculopathy.

Authors:  Alison Lap-tak Ma; Wai-ming Lai; Man-Chun Chiu; Niko Kei-chiu Tse
Journal:  Clin Exp Nephrol       Date:  2012-11-09       Impact factor: 2.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.